7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5 Remdesivir Intermediate COVID-19
Mea Hana Hana Kalepa Remdesivir a me nā mea pili i waena me ke kūlana kiʻekiʻe
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Kūwaena CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Inoa Kimia | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine |
Nā huaʻōlelo like | 4-Amino-7-bromopyrrolo [2,1-f] [1,2,4] triazine;ʻO ka haumia Remdesivir 2 |
Helu CAS | 937046-98-5 |
Helu CAT | RF-PI305 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
ʻĀpana Molekala | C6H5BrN4 |
Kaumaha Molecular | 213.04 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Pauda Melemele Māmā |
Infrared Spectrum | Kūlike i ka hoʻolālā |
NMR | Kūlike i ka hoʻolālā |
Maemae | ≥97.0% |
Nalo ma ka maloo | ≤1.0 |
Hoʻokahi haumia | ≤1.0% |
Nā Metala Kaumaha | ≤20ppm |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Ka waena o Remdesivir (CAS 1809249-37-3) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO 7-Bromopyrrolo [2,1-f] [1,2,4] triazin-4-amine (CAS 937046-98-5) he Intermediate o Remdesivir (CAS 1809249-37-3).ʻO Remdesivir kahi lāʻau antiviral me ka hana e kūʻē i ka maʻi maʻi hanu maʻi koʻikoʻi coronavirus 2 (SARS-CoV-2).ʻO Remdesivir (ʻike ʻia ʻo Veklury a i ʻole GS-5734) he SARS-CoV-2 nucleotide analog RNA polymerase inhibitor i hōʻike ʻia no nā pākeke a me nā maʻi maʻi pediatric (12 mau makahiki a ʻoi aʻe a me ke kaupaona ʻana ma kahi o 40 kg) no ka mālama ʻana i ka maʻi coronavirus 2019 (COVID-19) e koi ana i ka halemai.Pono e lawelawe ʻia ʻo Remdesivir i loko o kahi haukapila a i ʻole kahi wahi mālama olakino hiki ke hāʻawi i ka mālama koʻikoʻi e hoʻohālikelike ʻia me ka mālama haukapila inpatient.Ua hoʻokumu mua ʻia ʻo Remdesivir ma ke ʻano he anti-viral e kūʻē i ka maʻi Ebola, akā mai ka mea i hōʻike ʻia e hoʻemi i nā ukana viral o kekahi mau maʻi RNA me ka respiratory syncytial virus (RSV) a me nā β-coronaviruses e like me SARS-CoV, MERS-CoV, a me ke kumu kumu o COVID-19, SARS-CoV-2.